Dynamics of the power-duration relationship during prolonged endurance exercise and influence of carbohydrate ingestion by Clark, IE et al.
1 
 
Dynamics of the power-duration relationship during prolonged endurance 1 
exercise and influence of carbohydrate ingestion  2 
 3 
 4 
Ida E. Clark1, Anni Vanhatalo1, Christopher Thompson1, Charlotte Joseph1, Matthew I. 5 
Black1, Jamie R. Blackwell1, Lee J. Wylie1, Rachel Tan1, Stephen J. Bailey1, Brad W. 6 
Wilkins2, Brett S. Kirby2 and Andrew M. Jones1 7 
 8 
1Sport and Health Sciences, College of Life and Environmental Sciences,  St. Luke’s Campus, 9 
University of Exeter, Heavitree Road, Exeter, EX1 2LU, United Kingdom; 2Nike Sport 10 
Research Lab, One SW Bowerman Dr, Beaverton 97005, USA. 11 
 12 
Address for Correspondence: 13 
Andrew M Jones PhD 14 
Sport and Health Sciences 15 
University of Exeter 16 
United Kingdom 17 
Tel: 01392 262815 18 
E-mail: a.m.jones@exeter.ac.uk  19 
 20 
  21 
2 
 
Abstract  22 
We tested the hypotheses that the parameters of the power-duration relationship, estimated as 23 
the end-test power (EP) and work done above EP (WEP) during a 3-min all out exercise test 24 
(3MT), would be reduced progressively following 40 min, 80 min and 2 h of heavy-intensity 25 
cycling, and that carbohydrate (CHO) ingestion would attenuate the reduction in EP and 26 
WEP. Sixteen participants completed a 3MT without prior exercise (control), immediately 27 
after 40 min, 80 min and 2-h of heavy-intensity exercise while consuming a placebo beverage, 28 
and also after 2-h of heavy-intensity exercise while consuming a CHO supplement (60 g/h 29 
CHO). There was no difference in EP measured without prior exercise (260 ± 37 W) 30 
compared to EP following 40 min (268 ± 39 W) or 80 min (260 ± 40 W) of heavy-intensity 31 
exercise; however, after 2-h, EP was 9% lower compared to control (236 ± 47 W; P<0.05). 32 
There was no difference in WEP measured without prior exercise (17.9 ± 3.3 kJ) compared to 33 
after 40 min of heavy-intensity exercise (16.1 ± 3.3 kJ), but WEP was lower (P<0.05) than 34 
control after 80 min (14.7 ± 2.9 kJ) and 2-h (13.8 ± 2.7 kJ). Compared to placebo, CHO 35 
ingestion negated the reduction of EP following 2-h of heavy-intensity exercise (254 ± 49 W) 36 
but had no effect on WEP (13.5 ± 3.4 kJ). These results reveal a different time course for the 37 
deterioration of EP and WEP during prolonged endurance exercise and indicate that EP is 38 
sensitive to CHO availability.       39 
  40 
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New and Noteworthy 41 
 42 
The parameters of the power-duration relationship (critical power, CP, and the curvature 43 
constant, W') have typically been considered to be static. Herein, we report the time course for 44 
reductions in CP and W', as estimated using the 3-min all-out cycle test, during 2 h of heavy-45 
intensity exercise. We also show that carbohydrate ingestion during exercise preserves CP, 46 
but not W', without altering muscle glycogen depletion. These results provide new 47 
mechanistic and practical insight into the power-duration curve and its relationship to 48 
exercise-related fatigue development.  49 
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Introduction 50 
The parameters of the hyperbolic power-duration relationship, the critical power (CP) and the 51 
curvature constant (W′, which represents a fixed work capacity above CP), are important 52 
determinants of endurance exercise performance (25, 32, 50). CP is considered to be a 53 
metabolic or fatigue threshold which separates the ‘heavy’ from the ‘severe’ exercise intensity 54 
domains (8, 40, 41). In the heavy-intensity domain (<CP), intramuscular metabolic 55 
homeostasis is maintained and pulmonary V̇O2 attains a delayed steady-state (4, 26, 41). In 56 
contrast, in the severe-intensity domain (>CP), intramuscular metabolic homeostasis is not 57 
achieved, a V̇O2 ‘slow component’ develops that drives V̇O2 inexorably to its maximum, and 58 
exercise tolerance is predictably limited as a function of the power output above CP and the 59 
size of the Wʹ (4, 26, 40, 41).   60 
The CP and W′ are conventionally estimated using 3-5 severe-intensity prediction trials in 61 
which constant power outputs are maintained until the limit of tolerance, with the asymptote 62 
(representing CP) and the curvature constant (representing W′) of the power-time relationship 63 
subsequently being determined mathematically (30, 41, 48). More recently, a 3-min all-out 64 
cycle test against fixed resistance (3MT) has been developed, during which external power 65 
output declines hyperbolically with time, which permits a more expeditious assessment of CP 66 
and W′ (7, 48). The 3MT has been shown to provide valid and reliable estimates of CP and 67 
Wʹ, where the mean power output during the last 30 s of the test (end-test power, EP) 68 
represents CP, and the work completed above EP (WEP) represents Wʹ (7, 38, 48). We have 69 
recently reported that the 3MT continues to provide valid (13) and reasonably reliable (12) 70 
estimates of CP and W′ following 2 h of heavy-intensity cycle exercise. In these studies we 71 
found that prolonged endurance exercise consistently and profoundly altered the power-time 72 
relationship, with CP and EP falling by ~10% and W′ and WEP falling by ~20% (12, 13). 73 
These results have important implications for our understanding of fatigue development, and 74 
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for performance prognosis, during endurance exercise. At present, however, the time course 75 
over which EP and WEP deteriorate during prolonged endurance exercise is not known. 76 
Elucidating the dynamic changes in EP and WEP during prolonged exercise may provide 77 
insight into the determinants of fatigue and underpin the development of interventions to 78 
attenuate the decline in performance during such exercise.    79 
The mechanistic bases for the reductions in EP and WEP after 2 h of heavy-intensity exercise 80 
are likely multifactorial, and may include muscle glycogen depletion (12, 13, 30). It is well 81 
known that glycogen depletion increases with the duration of heavy-intensity exercise (17, 82 
18). If glycogen depletion impacts the power-duration relationship, then reductions in EP and 83 
WEP would be expected to become much more substantial following longer, compared to 84 
shorter, bouts of heavy-intensity exercise. Carbohydrate (CHO) ingestion is known to benefit 85 
prolonged endurance exercise performance by sparing muscle [glycogen], better maintaining 86 
blood [glucose] and/or providing stimulation to the central nervous system via the ‘pleasure 87 
and reward’ centers of the brain (21, 23). During long-duration events, which deplete muscle 88 
glycogen stores, exogenous CHO intake is particularly important to maintain high rates of 89 
CHO oxidation (20), with the greatest performance enhancement observed at ingestion rates 90 
of 60-80 g/h (44). While the reductions in EP and WEP were not significantly correlated with 91 
changes in muscle [glycogen] following 2 h of heavy-exercise in our previous study (13), the 92 
relationship between muscle CHO availability (in the muscle and circulation) and the power-93 
time relationship is likely to be complex, and it is possible that CHO ingestion may offset the 94 
reductions in EP and WEP reported following 2 h of heavy-intensity cycling (12, 13) 95 
The purpose of this study was to: 1) investigate the dynamic changes in EP and WEP during 96 
and following 2 h of heavy-intensity exercise; and 2) determine the effect of 60 g/h of CHO 97 
ingestion, compared to a placebo, on EP and WEP during and following 2 h of heavy-98 
intensity exercise. We hypothesized that EP and WEP would be reduced progressively 99 
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following 40 min, 80 min and 2 h of heavy-intensity exercise, and that CHO ingestion would 100 
attenuate the declines in EP and WEP after 2 h of heavy-intensity exercise. 101 
 102 
Methods 103 
This paper reports the results of two experiments. The first experiment was conducted to 104 
investigate possible changes in EP and WEP after 40 min, 80 min and 2 h of heavy-intensity 105 
exercise and the second experiment was conducted to investigate the effect of CHO ingestion 106 
on changes in EP and WEP after 2 h of heavy-intensity exercise.  107 
Participants 108 
Experiments I and II were conducted on the same group of participants. Sixteen males (mean 109 
± SD: age = 34 ± 6 years, height = 1.78 ± 0.07 m, body mass = 79.1 ± 7.6 kg, peak O2 uptake 110 
(V̇O2peak) = 52.5 ± 7.3 mLꞏkg-1ꞏmin-1) took part in the experiments. They were all competitive 111 
athletes (comprising two runners, six cyclists, four triathletes, three Crossfit athletes, and one 112 
squash player) but were not professional/elite. The participants were instructed to arrive at the 113 
laboratory in a rested and hydrated state, to avoid alcoholic drinks and strenuous exercise for 114 
24 h prior to testing, and to maintain their habitual diet throughout the study. The participants 115 
recorded their diet for 24 h prior to the first experimental session and replicated this prior to 116 
each subsequent visit. The experimental procedures were approved by the Institutional 117 
Research Ethics Committee at the University of Exeter and informed consent was obtained 118 
from each participant prior to testing. One participant did not consent to having muscle 119 
biopsies taken in Experiment II. All exercise tests were separated by a minimum of 24 h but 120 
the tests in which the 3MT was completed following a bout of heavy-intensity exercise (see 121 
below for more details) were separated by at least 72 h (i.e., 7 ± 4 days). 122 
Experimental design 123 
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Participants reported to the laboratory on 7 occasions over a 7-week period (± 2 weeks). The 124 
tests included a ramp incremental exercise test for the determination of V̇O2peak and gas 125 
exchange threshold (GET), a 3MT familiarisation trial, a 3MT performed in a rested state 126 
which served as a control (C-3MT), and on subsequent visits: a 3MT preceded by 40 min (40-127 
3MT), 80 min (80-3MT) or, on two occasions, 2 h of heavy-intensity exercise. A placebo 128 
drink was consumed during the 40-3MT, 80-3MT and during one of the 2 h visits (120-129 
3MTPLA), while CHO was consumed during one 2 h visit (120-3MTCHO). The 120-3MTPLA 130 
visit was used for both experiments. The other trials were administered in a randomized and 131 
counterbalanced order.  132 
All exercise tests were conducted using the same electrically-braked cycle ergometer (Lode 133 
Excalibur Sport, Groningen, Netherlands). During all tests, except the 3MTs, the participants 134 
cycled at a self-selected pedal rate (70-90 rpm). For each participant, the self-selected pedal 135 
rate used in the ramp incremental test was recorded and replicated in each subsequent visit. 136 
The ergometer seat and handlebar configuration were adjusted for comfort during the first 137 
visit and were recorded and then replicated in subsequent visits. Exercise tests took place in 138 
an air-conditioned laboratory with ambient temperature of 20oC and relative humidity of 60%.  139 
Determination of V̇O2peak and gas exchange threshold 140 
During visit 1 the participants completed a ramp incremental exercise test. The ramp protocol 141 
consisted of a 3-min baseline of pedalling at 20 W after which the power output was increased 142 
by 30 W/min until the participant was unable to continue. The limit of tolerance was 143 
determined when cadence fell >10 rpm below the target cadence for more than 5 s despite 144 
strong verbal encouragement. V̇O2peak was determined as the highest 30-s mean value 145 
recorded during the test. The GET was defined according to the procedures of Beaver et al. 146 
(2). The GET and V̇O2peak were used to normalize the fixed resistance for the 3MTs.  147 
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Three-min all-out tests (3MTs) 148 
The resistance for the 3MT was applied using the linear factor function of the ergometer and 149 
was calculated as: linear factor = power output/preferred cadence2 where the power was 150 
50%∆ (i.e., GET plus 50% of the interval between the GET and ramp test peak power output). 151 
Visit 2 (familiarization test) and visit 3 consisted of a C-3MT performed with no prior 152 
exercise. The 3MT protocol began with a 3-min baseline of pedalling at 20 W. During visits 153 
4-7, a 60 s pause was administered after the constant power output bout, during which the 154 
participants had 30 s of passive recovery and then were instructed to cycle for the last 30 s 155 
against a resistance of 20 W. This was done to replicate the 1-min pause that was required to 156 
obtain a muscle biopsy in Experiment II. A 5 s countdown was given prior to the 3MT and the 157 
participant was instructed to increase cadence to ~110-120 rpm. Strong verbal encouragement 158 
was then given for an all-out effort from the onset of the 3MT. Participants were not informed 159 
of the elapsed time. Instructions were given to reach peak power output as quickly as possible 160 
and to maintain the all-out effort throughout the test. The EP was subsequently calculated as 161 
the mean power output over the last 30 s of the test, and the WEP was calculated as the work 162 
done above EP during the 3MT, i.e. the mean power output above EP for each second of the 163 
test was multipled by the number of seconds of exercise performed above EP to compute the 164 
total work done above EP (48). The results of the 3MT were deemed valid only when the 165 
V̇O2peak attained exceeded 95% of the V̇O2peak determined in the initial ramp incremental test. 166 
Results determined from the C-3MT, 40-3MT, 80-3MT, 120-3MTPLA and 120-3MTCHO were 167 
consequently termed C-EP and C-WEP, 40-EP and 40-WEP, 80-EP and 80-WEP, 120PLA-EP 168 
and 120PLA-WEP, 120CHO-EP and 120CHO-WEP, respectively.  169 
Experiment I: Effect of 40 min, 80 min and 2 h of heavy-intensity exercise on the parameters 170 
of the power-duration relationship 171 
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The constant power output applied during the 40 min, 80 min and 2 h heavy-intensity exercise 172 
bouts was calculated as the power output at the GET plus 25% of the difference between the 173 
GET and C-EP (25%∆1; 12). Experiment I consisted of three heavy-intensity exercise bouts 174 
of 40 min, 80 min and 2 h followed by a 3MT. The visits began with a 3-min baseline of 175 
pedaling at 20 W for attainment of baseline measurements, after which the power output 176 
abruptly increased to the target power output for 40 min, 80 min or 2 h. Participants were 177 
instructed to hold their desired cadence throughout the constant power output bout. 178 
Participants were provided with a 100-ml  opaque plastic bottle containing 1 mL of apple-179 
flavored sweetener (Myprotein.Co, UK), with no caloric value, added to 94 mL of water  to 180 
ensure that supplements were indistinguishable from, and of equal volume to, the CHO 181 
solution used in Experiment II (see below). The first bottle was given at -3 min, as 182 
participants wore a mask between -3 – 15 min for measurements of pulmonary gas exchange, 183 
and thereafter a bottle was given every 15 min. During the 40-3MT the last beverage was 184 
consumed at 30 min; during the 80-3MT visit the last beverage was consumed at 75 min; and 185 
during the 120-3MTPLA the last beverage was consumed at 105 min. A clock with time 186 
remaining was visible during the constant power output bout and participants were allowed to 187 
listen to music; however, both were withdrawn 2 min prior to the 3MT. Participants were 188 
instructed to stop pedalling for 30 s after the constant power output bout, and at 30 s, they 189 
were instructed to start cycling again at 20 W. This was administered to ensure the same rest 190 
period was provided between the four constant power output tests (both experiments) and the 191 
3MTs and so that muscle biopsies could be taken in the 30 s window during the 2 h visits for 192 
experiment II. Pulmonary gas exchange data were attained at the following time points during 193 
the 40-3MT visit: -3-15, 25-30 and 35-40 min; the 80-3MT visit: -3-15, 25-30, 55-60 and 75-194 
80 min; and the 120-3MTPLA visit: -3-15, 25-30, 55-60, 85-90 and 115-120 min; and 195 
continuously throughout the 3MT. A blood sample from a fingertip was collected every 20 196 
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min during the constant power output bouts for the analysis of [lactate] and [glucose]. Heart 197 
rate (HR) was recorded (Garmin FR70, Garmin Ltd, Schaffhausen, Switzerland) every 5 s 198 
during all visits. Before and after the test, participants were weighed in minimal clothing to 199 
assess changes in body mass.  200 
Experiment II: Effect of CHO ingestion on the parameters of the power-duration relationship 201 
The 120-3MTPLA and 120-3MTCHO visits included 2 h of heavy-intensity exercise 202 
immediately followed by a 3MT. The 120-3MTPLA exercise trial was the same as that in 203 
Experiment I. The procedures for the 120-3MTCHO visit were identical to the 2 h visit 204 
described in Experiment I, except for the ingestion of CHO. During the 120-3MTCHO visit 205 
participants consumed 60g/h of CHO (Maurten drink mix 320, Biotech center, Gothenburg, 206 
Sweden). Participants were given the same bottle as described in Experiment I, containing 94 207 
ml of Maurten drink mix (15g of CHO), every 15 min during the constant power output bout. 208 
A muscle biopsy was taken prior to exercise and again at 120 min during the 30 s rest period 209 
between the constant-power-output bout and the 3MT.  210 
Measurements 211 
Pulmonary gas exchange. Pulmonary gas exchange was measured breath-by-breath and 212 
averaged over 10 s periods during all visits. Participants wore a face mask (Hans Rudolf 7450 213 
Series V2TM Mask, CareFusion, Germany) and inspired and expired gas volume and gas 214 
concentration signals were sampled continuously at 100 Hz (Vyntus, CareFusion, Germany) 215 
via a capillary line connected to the mask. These analysers were calibrated before each test 216 
with gases of known concentration and the turbine volume transducer was calibrated using a 217 
3-L syringe (Hans Rudolph, MO). The volume and concentration signals were time-aligned 218 
by accounting for the delay in capillary gas transit and analyzer rise time relative to the 219 
volume signal. The baseline V̇O2 period during all visits were defined as the mean value 220 
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recorded over the final minute during the 3-min warm up period at 20 W. Fat and CHO 221 
oxidation rates were calculated from V̇O2 and V̇CO2 using the following stoichiometric 222 
equations with the assumption that protein oxidation during exercise did not change (24):  223 
CHO oxidation (gꞏmin-1) = [4.21 (V̇CO2) – 2.692 (V̇O2)] 224 
Fat oxidation (gꞏmin-1) = [1.695 (V̇O2) – 1.701 (V̇CO2)] 225 
Muscle biopsies. Muscle samples were obtained from one incision from the medial region of 226 
the m. vastus lateralis under local anesthesia (1% lidocaine) using the percutaneous 227 
Bergström needle biopsy technique under suction (3). Muscle samples were taken at rest and 228 
immediately post 2 h of heavy-intensity exercise during the 120-3MTCHO and 120-3MTPLA 229 
visits. The post-exercise biopsies were taken while participants remained on the cycle 230 
ergometer and were typically collected within 10 s of the completion of the exercise 231 
bout.  Biopsy samples were immediately frozen in liquid nitrogen and stored at 80°C for 232 
subsequent analysis.  233 
Muscle glycogen concentration. Muscle samples were freeze-dried prior to dissection from 234 
connective tissue, fat and blood. Muscle glycogen was extracted from ~1 mg d.w. muscle and 235 
hydrolysed to glucose units in 1M HCl at 95°C for 3 h. The addition of hexokinase catalyzed 236 
the reaction of glucose with adenosine triphosphate to glucose-6-phosphate, and then to 6-P-237 
gluconolactone with NADH+ in the presence of G-6-PDH enzyme, producing the fluorescent 238 
detectable NADPH (28). Reactions were measured on a Fluoroskan (Fluoroskan™ Microplate 239 
Fluorometer, ThermoFisher Scientific, Mass. USA), with Excitation 355 nm and Emission 240 
460 nm filters. Glycogen was reported in units of mmol of glucose per kg dry muscle. 241 
Blood analyses. All fingertip blood samples (~25 µl) (visit 4-7) were collected into capillary 242 
tubes and analysed within 60 s for blood [lactate] and [glucose] using an automated lactate 243 
analyser (Stat2300, Yellow Spring Instrument, Yellow Springs, OH).  244 
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Statistical analysis 245 
For experiment I, one-way ANOVAs with repeated measures were used to assess differences 246 
over time during the 40-3MT, 80-3MT and 120-3MTPLA tests in respiratory gas exchange 247 
variables, HR, blood [lactate] and blood [glucose]. To assess the difference in these 248 
physiological variables at common time points within the 40-3MT, 80-3MT and 120-3MTPLA 249 
a repeated measures ANOVA (condition x time) was used. One-way  ANOVA with repeated 250 
measures was used to assess differences in EP, WEP, total work done (TWD), peak power 251 
output, V̇O2peak, and body mass between C-3MT, 40-3MT, 80-3MT and 120-3MTPLA.  252 
For experiment II, one-way ANOVAs with repeated measures were used to assess differences 253 
in the EP,WEP, TWD, peak power output, muscle glycogen concentration and V̇O2peak, as 254 
well as differences in respiratory gas exchange variables, blood [glucose] and blood [lactate] 255 
between C-3MT, 120-3MTPLA and 120-3MTCHO. Differences in the change in muscle 256 
[glycogen] (from rest to post-exercise) between the 120-3MTPLA and 120-3MTCHO visits were 257 
analysed using a paired sample t-test. The relationships between the change in muscle 258 
[glycogen] and the changes in in EP and WEP were determined using Pearson product-259 
moment correlation coefficients.  260 
Statistical significance was accepted at P<0.05. Significant interactions and main effects were 261 
followed up with Bonferroni post hoc tests. Data are reported as mean ± SD. 262 
 263 
Results 264 
 265 
The V̇O2peak in the ramp incremental test was 4.12 ± 0.45 Lꞏmin-1, the peak power output was 266 
360 ± 41 W and the GET was 132 ± 7 W. The 25%∆1 for the 2 h constant power output bouts 267 
was 164 ± 28 W.  268 
 269 
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Experiment I: Dynamic changes in the parameters of the power-duration relationship 270 
following 40 min, 80 min and 2 h of heavy-intensity exercise 271 
During the 40-3MT visit, the relative intensity did not change between 10-15 min (63% ± 7% 272 
V̇O2peak) and 35-40 min (63% ± 5% V̇O2peak; P>0.05). The relative intensity increased during 273 
both the 80-3MT visit (from 10-15 min: 63% ± 7% V̇O2peak to 75-80 min: 65% ± 5 % V̇O2peak; 274 
P<0.05) and the 120-3MTPLA visit (from 10-15 min: 64% ± 8% V̇O2peak to 115-120 min: 68% 275 
± 7% V̇O2peak; P<0.001). HR increased over time during all the constant power output bouts 276 
(Table 1). During the 40-3MT visit, RER did not change significantly from 10-15 min to 35-277 
40 min; however, RER decreased during both the 80-3MT and the 120-3MTPLA visits (Table 278 
1).  279 
Body mass decreased during the 40-3MT, 80-3MT and 120-3MTPLA trials (Table 1). Body 280 
mass was lower post-exercise in the 120-3MTPLA visit compared to the 80-3MT and 40-3MT 281 
visits with no differences between the 80-3MT and the 40-3MT visit (Table 1).  282 
The power output profiles during the C-3MT, 40-3MT, 80-3MT and 120-3MTPLA are shown 283 
in Fig. 1. There were no differences in V̇O2peak between C-3MT (4.03 ± 0.40 Lꞏmin-1), 40-284 
3MT (4.19 ± 0.40 Lꞏmin-1), 80-3MT (4.15 ± 0.41 Lꞏmin-1), 120-3MTPLA (4.08 ± 0.51 Lꞏmin-1) 285 
and the ramp incremental test (P>0.05). There was no differences in EP between C-EP (260 ± 286 
37 W), 40-EP (268 ± 39 W) and 80-EP (260 ± 40 W; P>0.05). However, 120PLA-EP was 287 
lower than EP in all the other conditions (236 ± 47 W; P<0.05; Fig. 2A). There was no 288 
difference in WEP between C-WEP (17.9 ± 3.3 kJ) and 40-WEP (16.1 ± 3.3 kJ), but both 80-289 
WEP (14.7 ± 2.9 kJ; P<0.05) and 120PLA-WEP (13.8 ± 2.7 kJ; P<0.05) were lower than C-290 
WEP; 80-WEP was also lower than 40-WEP (P<0.05; Fig. 2B). Results for peak power 291 
output and TWD during the 3MTs are shown in Fig. 2C and Fig. 2D, respectively. Blood 292 
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[lactate] immediately after the 3MT was higher in the 40-3MT (8.8 ± 2.1 mM) compared to 293 
the 120-3MTPLA visit (7.0 ± 2.1 mM; P<0.05) with no difference after any other 3MTs.  294 
Experiment II: Influence of CHO ingestion on changes in the power-duration relationship 295 
following 2 h of heavy-intensity exercise 296 
In both the 120-3MTPLA and 120-3MTCHO tests, the relative intensity increased from ~64% 297 
V̇O2peak at 10-15 min to ~68% V̇O2peak at 115-120 min (Fig. 3A). HR increased during both 298 
120-3MT visits (Table 1). There was no difference in relative intensity or HR between the 299 
120-3MTCHO and 120-3MTPLA visits at any time point (Table 1 and Fig. 3A). RER decreased 300 
during both the 120-3MTCHO and 120-3MTPLA visits, but was higher at 115-120 min in the 301 
120-3MTCHO trial compared to the 120-3MTPLA (Fig. 3B). CHO oxidation was higher in the 302 
120-3MTCHO bout compared to the 120-3MTPLA bout at 85-90 and 115-120 min (Fig. 3C). 303 
Blood [glucose] was higher during the 120-3MTCHO bout compared to 120-3MTPLA at all time 304 
points at and beyond 40 min (Fig. 3D). There was no difference in blood [lactate] measured 305 
during the 120-3MTCHO and 120-3MTPLA trials. However, blood [lactate] was higher post 306 
3MT during the 120-3MTCHO (8.4 ± 0.5 mM) compared to the 120-3MTPLA visit (7.2 ± 0.5 307 
mM; P<0.05).  308 
The power output profiles during the C-3MT, 120-3MTCHO and 120-3MTPLA are shown in 309 
Fig. 4. There were no differences in V̇O2peak between C-3MT, 120-3MTCHO, 120-3MTPLA and 310 
the ramp incremental test (P>0.05). 120PLA-EP was 9% lower (236 ± 47 W) than C-EP (260 ± 311 
37 W; P<0.05) and 7% lower than 120CHO-EP (254 ± 49 W; P<0.05; Fig. 5A). 120CHO-EP 312 
was not different from C-EP (Fig. 5A). C-WEP was 22% higher (17.9 ± 3.3 kJ) than 120PLA-313 
WEP (13.8 ± 2.7 kJ; P<0.001) and 24% higher than 120CHO-WEP (13.5 ± 3.4 kJ; P<0.001; 314 
Fig. 5B). 120CHO-WEP was not different from 120PLA-WEP (Fig. 5B). Results for peak power 315 
output and TWD are shown in Fig. 5C and Fig. 5D, respectively.  316 
15 
 
There was insufficient muscle tissue in one biopsy sample for completion of muscle glycogen 317 
analyses, and therefore the muscle glycogen data are for n=14. Muscle [glycogen] decreased 318 
over the 2 h heavy-intensity exercise bouts in both the 120-3MTCHO and 120-3MTPLA trial 319 
(Fig. 6). Muscle [glycogen] was lower following the 2 h bout in the 120-3MTPLA trial 320 
compared to 120-3MTCHO trial; however, the change in muscle [glycogen] was not different 321 
between trials (Fig. 6). There was no correlation between the change in muscle [glycogen] 322 
over the 2 h exercise bout and the changes in EP or WEP in either the 120-3MTPLA or the 120-323 
3MTCHO bout.  324 
To increase sample size and therefore increase confidence in our analysis, we combined the 325 
data from the present study with those from Clark et al. (13) to create a data set containing 28 326 
participants who underwent muscle biopsies and completed a 3MT both at rest and following 327 
2 h of heavy-intensity exercise. The pooled data show that muscle [glycogen] at rest was 328 
correlated with control EP (Fig. 7A) and that muscle [glycogen] following 2 h of heavy-329 
intensity exercise was correlated with both fatigued EP (Fig. 7B) and fatigued WEP (r = 0.43; 330 
P<0.05). The change in EP following 2 h of heavy-intensity exercise was not correlated with 331 
the change in muscle [glycogen] (Fig. 8C, 8D). However, the percentage change in muscle 332 
[glycogen] following 2 h of heavy-intensity exercise was correlated with both the absolute 333 
change in WEP (Fig. 7E) and the percentage change in WEP (Fig. 7F).  334 
 335 
Discussion 336 
 337 
This is the first study to investigate the influence of different durations of prolonged 338 
endurance exercise, and CHO ingestion during exercise, on the parameters of the power-339 
duration relationship. We used the 3MT as a practical and expeditious method to appraise 340 
changes in the power-duration relationship because it has been shown that the EP and WEP 341 
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provide valid estimates of CP and W′, respectively, both in the absence of prior exercise (7, 342 
48) and following 2 h of heavy-intensity cycle exercise (13). The principal novel findings 343 
were that: (1) EP was not altered by 40 min or 80 min but was significantly reduced after 2 h 344 
of heavy-intensity exercise; (2) WEP was not altered by 40 min but was significantly reduced 345 
after 80 min and 2 h of heavy-intensity exercise; (3) the reduction in EP following 2 h of 346 
heavy-intensity exercise was negated when CHO was consumed; and (4) the reduction in 347 
WEP following 2 h of heavy-intensity exercise was not rescued by CHO ingestion. These 348 
results reveal disparate time courses for the changes in EP and WEP during heavy-intensity 349 
exercise: WEP appears to fall in an approximately linear fashion and becomes significantly 350 
reduced when exercise duration ≥80 min; while EP is preserved for at least 80 min and is only 351 
significantly reduced when exercise duration approaches 2 h. Importantly, our results show 352 
that EP (but not WEP) is preserved following 2 h of heavy-intensity exercise when 60 g/h 353 
CHO is consumed, suggesting that CP (but not W′) is influenced, at least in part, by CHO 354 
feeding. These findings may have significant implications for performance prediction and the 355 
formulation of optimal race (pacing and nutritional) strategies. 356 
I: Dynamic changes in the parameters of the power-duration relationship following 40 min, 357 
80 min and 2 h of heavy-intensity exercise 358 
Consistent with our previous research, we found that 2 h of heavy-intensity exercise led to a 359 
decline of both EP and WEP (12, 13). Specifically, there was a ~9% fall in EP and a ~22% 360 
fall in WEP compared to C-3MT, results which are in close agreement with our previous 361 
findings of an 8-11% reduction in EP and a 20-22% reduction in WEP following 2 h of 362 
heavy-intensity exercise (12, 13). The key novel findings of the present study were that there 363 
were no significant changes in either EP or WEP compared to the control condition following 364 
40 min of heavy-intensity exercise whereas, following 80 min of exercise, EP was unchanged 365 
but WEP was significantly reduced (by 17%). Our study therefore reveals differences in the 366 
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time course of changes in EP and WEP during endurance exercise, with WEP deteriorating 367 
more rapidly than EP. These results may provide insight into the physiological mechanisms 368 
underpinning the power-duration relationship and their relationship with the fatigue process 369 
during endurance exercise.    370 
Several factors likely contribute to the changes observed in the power-duration parameters 371 
following 80 min and/or 2 h of heavy-intensity exercise. An increase in the O2 cost of 372 
sustaining the constant power output was observed during the 2 h (from ~64% to ~68% of 373 
initial V̇O2peak) and 80 min (from ~63% to ~65% of initial V̇O2peak) but not the 40 min 374 
exercise bout (stable at ~63% of initial V̇O2peak) and occurred concomitantly with a decrease 375 
in RER in the 2 h (from ~0.91 to ~0.84) and 80-min (from ~0.93 to ~0.91) exercise bouts but 376 
not in the 40 min bout (from ~0.93 to ~0.92). The progressive loss of efficiency is therefore 377 
related in part to a shift in substrate utilisation from CHO towards fat oxidation during the 80 378 
min and 2 h exercise bouts. Given that EP reflects a critical oxidative metabolic rate (1), a loss 379 
of efficiency (i.e., a higher V̇O2 per watt of power output) would necessarily result in a 380 
reduced EP.  381 
A substantially increased core temperature and consequent redistribution of blood flow away 382 
from skeletal muscle to facilitate heat exchange might also increase the overall O2 cost of 383 
exercise (36). Moreover, significant dehydration, due to the sweat rate exceeding the rate of 384 
fluid replacement, could compromise cardiac output and muscle O2 delivery (42). Given that 385 
EP is an index of oxidative metabolic function (29, 47), these changes could reduce efficiency 386 
and/or exacerbate muscle metabolic perturbation and fatigue development. In our study, 387 
however, participants exercised in an air-conditioned lab (20o C) and consumed 380 ml of 388 
fluid per hour, pro rata, such that body mass losses were minimal (≤1.0 kg; ≤1.2%). Such 389 
small changes in body mass suggest that issues related to thermoregulation probably did not 390 
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contribute appreciably to the decline in 3MT performance we observed and certainly indicate 391 
that, if hyperthermia did occur, it likely affected subjects similarly.      392 
It appears that CP represents an important boundary for neuromuscular fatigue development 393 
(9, 40) such that central fatigue, which may be determined by a reduction in voluntary 394 
activation measured by motor nerve stimulation, makes a greater contribution to fatigue 395 
development in the heavy-intensity domain compared to the severe-intensity domain (4, 9, 396 
46). It is possible, therefore, that the development of central fatigue during the 80 min and 2 h 397 
heavy-intensity exercise bouts in the present study impaired performance in the subsequent 398 
3MT, reducing EP and/or WEP. Consistent with this interpretation, it has been reported that 399 
acetaminophen ingestion, which would be expected to blunt central fatigue development by 400 
attenuating the sensation of pain and preventing any reduction in central motor drive, led to 401 
greater muscle activation over the last 30 s of a 3MT and a higher EP compared to the placebo 402 
condition (31).   403 
The reduction in WEP after just 80 min as well as after 2 h of heavy-intensity exercise is 404 
intriguing. Significant changes in muscle [ATP] and/or muscle metabolic status (i.e. 405 
substantial depletion of phosphocreatine or accumulation of hydrogen ions) would not be 406 
anticipated during heavy-intensity exercise (4) such that the development of peripheral fatigue 407 
through these mechanisms is unlikely to explain the reduced WEP. The lack of effect on peak 408 
power output during the 3MT following 80 min and 2 h of heavy-intensity exercise might 409 
suggest that the reduced WEP at these time points is related not to high-energy phosphate 410 
depletion but rather to impaired ATP production via anaerobic glycolysis which may, in turn, 411 
be related to muscle glycogen depletion. Consistent with this, a reduction in WEP has been 412 
reported when glycogen depletion has been invoked by dietary restriction (30) or the 413 
performance of 2 h of heavy-intensity exercise (13). We note here that the evaluation of WEP 414 
is less reliable than EP (12) such that possible error in the estimates of WEP is a possible 415 
19 
 
limitation of the present study; however, the reduction in WEP at 80 min and 2 h of exercise 416 
is substantial relative to the likely error.     417 
When we combined the data from the present study with those from Clark et al. (13), we 418 
found a significant correlation between the change in WEP, but not EP, and the change in 419 
muscle [glycogen] following 2 h of heavy-intensity exercise. The progressive decline in 420 
muscle [glycogen] that would be expected during prolonged heavy-intensity exercise (18, 19) 421 
could therefore contribute to the reduction in WEP during the 80 min and 2 h exercise bouts. 422 
It is interesting to note, however, that WEP was significantly reduced despite muscle 423 
glycogen depletion being far from complete (~36% of the resting value was remaining 424 
following 2 h of exercise) at the start of the 3MT. An important consideration in this regard is 425 
that muscle glycogen depletion can be localised to subcellular compartments such that muscle 426 
performance might become impaired even when ‘global’ muscle [glycogen] appears sufficient 427 
(34). The present data suggest that absolute muscle [glycogen] may influence the rate of 428 
energy generation through anaerobic glycolysis, and/or influence contractile function via 429 
effects on sarcoplasmic reticulum calcium release (37), thereby reducing WEP.       430 
II: Influence of CHO ingestion on changes in the power-duration relationship following 2 h of 431 
heavy-intensity exercise 432 
We tested the hypothesis that changes in the power-duration relationship following 2 h of 433 
heavy-intensity exercise would be mitigated when CHO, compared to placebo, was consumed 434 
during exercise. A striking observation was that the reduction in EP following 2 h of heavy-435 
intensity exercise was eliminated by 60 g/h of CHO ingestion. Specifically, in the placebo 436 
condition, EP was reduced by 9% compared to C-EP, consistent with previous findings (12, 437 
13); however, when CHO was ingested during exercise, there was no significant reduction in 438 
EP compared to C-EP. In contrast, WEP was significantly reduced in both the placebo and 439 
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CHO conditions (22% and 24% reductions, respectively) compared to C-WEP, with there 440 
being no difference between the two conditions. An important novel finding of the present 441 
study is therefore that EP, but not WEP, may be preserved by CHO ingestion during 442 
endurance exercise of up to 2 h duration.  443 
Significant muscle glycogen depletion was evident following 2 h of heavy-intensity exercise 444 
both when subjects ingested CHO (53% reduction in [glycogen]) and when they ingested a 445 
placebo beverage (64% reduction in [glycogen]). Muscle [glycogen] was higher following 2 h 446 
of heavy-intensity exercise with CHO compared to placebo ingestion but this may be 447 
explained by the tendency for muscle [glycogen] to be higher at baseline in the CHO 448 
condition. The reduction in muscle [glycogen] over the 2 h exercise bout was not different 449 
between conditions despite there being greater CHO availability and utilization (evidenced by 450 
higher RER, a greater rate of CHO oxidation and higher blood [glucose]) when CHO was 451 
ingested. Similarly, Smith et al. (45) reported that ingestion of 60 g/h of CHO during 2 h of 452 
exercise at 77% of V̇O2peak did not spare muscle glycogen, compared to placebo, but did 453 
enhance subsequent 20-km time trial performance, an effect that the authors suggested was 454 
due to the increased rate of CHO oxidation. In light of the results of the present study, it is 455 
possible that the participants in Smith et al. (45) had a higher CP and could therefore sustain a 456 
higher power output during the 20-km time trial following CHO compared to placebo 457 
ingestion.  458 
The increased rate of CHO oxidation observed in the present study, consequent to CHO 459 
ingestion, likely contributed to the preserved EP we observed. However, given the greater 460 
proportional development of central fatigue during heavy-intensity endurance exercise (4, 9, 461 
46), it is possible that other factors also contributed. In the placebo condition, blood [glucose] 462 
was significantly lower than the baseline value at 100 and 120 min of exercise (~3.8 mM) 463 
whereas it remained stable throughout exercise in the CHO condition (~4.8 mM). It is 464 
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possible that this difference in blood [glucose] attenuated central fatigue development (14, 35) 465 
and enabled a higher muscle activation during the subsequent 3MT. Similarly, the detection of 466 
CHO by sensors in the mouth, even when the CHO is not swallowed, may attenuate 467 
decrements in exercise performance associated with fatigue (10, 16, 22). Specifically, it 468 
appears that CHO receptors in the oral cavity may signal an impending increase in CHO 469 
availability to higher brain regions (11, 16, 23). It is possible therefore that, in addition to 470 
direct effects on skeletal muscle metabolism, the ingestion of CHO during exercise reduced 471 
central fatigue and enabled enhanced motor output and contractile function (35) during the 472 
subsequent 3MT.     473 
In the present study, no significant correlations were found between the changes in muscle 474 
[glycogen] and EP or WEP in either condition, possibly due to the relatively small sample 475 
size. However, when the data from the present study were pooled with those of Clark et al. 476 
(13), we found a positive relationship between EP and muscle [glycogen] both at rest and 477 
following 2 h of heavy-intensity exercise. These results suggest a link between aerobic fitness 478 
and muscle glycogen storage, which might be mediated by training status (15). Moreover, 479 
when the data from the two studies were combined, we found that, following 2 h of heavy-480 
intensity exercise, muscle [glycogen] was correlated with WEP and also that the change in 481 
muscle [glycogen] over the 2 h exercise bout was correlated with the change in WEP.  482 
The physiological mechanisms underpinning W′ have not been entirely resolved (5, 33, 43). 483 
However, because CP is closely related to the proportion of type I muscle fibers (29, 47), it 484 
has been suggested that W′ may reflect the metabolic, contractile and/or fatigue-related 485 
characteristics of type II muscle fibers (47, 51). The fall in WEP we observed might therefore 486 
reflect the specific effects of 2 h of heavy-intensity exercise on the type II fiber population, 487 
including glycogen depletion (52). There is evidence to suggest that W′ is related to the 488 
capacity for substrate-level phosphorylation, with PCr availability being important for the 489 
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achievement of peak power output in the 3MT (39, 47, 49). It has been reported that W′ is 490 
reduced following glycogen depletion induced by dietary CHO restriction, with there being no 491 
effect on CP (30). The results of the current investigation are consistent with these findings in 492 
showing that WEP is reduced when glycogen depletion is evident following 2 h of heavy-493 
intensity cycling, irrespective of effects on EP.  494 
The different effect of CHO feeding during endurance exercise on EP and WEP provide novel 495 
insight into the mechanisms underpinning these parameters (and, by extension, CP and W′). 496 
While muscle glycogen depletion was not altered compared to the placebo condition, the 497 
maintenance of euglycaemia by CHO ingestion during prolonged exercise resulted in a 498 
preservation of EP in the face of a decline in WEP. This suggests that, following 2 h of heavy-499 
intensity exercise, EP may be modulated by central fatigue whereas WEP may be more 500 
directly related to muscle glycogen availability. Further studies are required, with more direct 501 
measurements of central and peripheral fatigue, to explore this possibility.     502 
Implications for Performance 503 
The results of the present study have several potentially important implications for athlete 504 
performance diagnostics and race practice. The disparate time courses for the degradation of 505 
EP and WEP we observed during prolonged endurance exercise is of particular interest. The 506 
maintenance of EP for ~80 min of such exercise indicates that performance for events which 507 
are sustained below EP can be faithfully predicted from measurements made in the rested 508 
state whereas, for longer events, the fall in EP render such predictions more complicated. 509 
Indeed, inter-individual variation in the reductions in EP and WEP during endurance exercise, 510 
reflecting fatigue resistance, is likely an important but previously overlooked component of 511 
success in endurance sports (12). The fall in WEP during heavy-intensity exercise occurred 512 
much earlier than the fall in EP, with the group mean reduction being 10% after 40 min (not 513 
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significant), 18% after 80 min and 23% after 2 h. This relatively early reduction in WEP may 514 
impact on an athlete’s ability to draw upon W′, limiting their ability to respond to, or initiate, 515 
surges in pace above CP, a factor that should be carefully considered when developing race 516 
tactics.  517 
Our findings also emphasise the importance of CHO consumption during prolonged 518 
endurance exercise by showing that ingestion of 60 g/h CHO enabled EP to be maintained 519 
compared to a 9% reduction in EP when placebo was consumed. The performance 520 
implications of this difference, whether measured in terms of the mean speed that may be 521 
sustained throughout a race or in the ability to finish strongly, are likely to be profound. 522 
Depending on the power being sustained and the extent of the fall in CP during prolonged 523 
endurance exercise, it is possible that an athlete may eventually transition from the heavy- to 524 
the severe-intensity exercise domain, with the inevitable outcome that power must fall and/or 525 
exercise will become intolerable. This highlights the important interaction between 526 
physiology and nutrition during endurance exercise. Maintaining a high rate of CHO ingestion 527 
while exercising at a high intensity is an important consideration, and a potential limiting 528 
factor, for extreme human endurance challenges such as the attempt to run a <2 h marathon 529 
(6, 27).           530 
It is important to acknowledge that our results are specific to the conditions of our study. 531 
Naturally, dynamic changes in EP and WEP would likely be different if other combinations of 532 
exercise intensity and duration were assessed. Moreover, the effect of CHO ingestion on the 533 
change in EP is also likely influenced by exercise intensity, exercise duration and the rate 534 
(and type) of CHO consumption (22). Finally, the extent to which our results in cycling may 535 
be extrapolated to other exercise modalities is presently unclear. These questions and the 536 
nature of the interaction between these key variables might be the subject of future 537 
investigations.  538 
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Conclusion 539 
In conclusion, the EP and WEP, surrogates of the parameters of the power-duration 540 
relationship, CP and Wʹ, respectively, were reduced following 2 h of heavy-intensity cycling. 541 
WEP, but not EP, was also reduced following 80 min of heavy-intensity cycling. CHO 542 
ingestion during 2 h of heavy-intensity cycling abolished the reduction in EP, but not WEP. 543 
These results suggest that, following prolonged endurance exercise, Wʹ may be sensitive to 544 
local muscle glycogen availability, presumably via a limitation to energy production by 545 
anaerobic glycolysis, whereas CP may be sensitive to global CHO availability, perhaps via its 546 
relationship with central fatigue development. Practitioners should be aware that dynamic 547 
changes in the parameters of the power-duration relationship during heavy-intensity exercise 548 
present a challenge to the use of these parameters to predict performance during endurance 549 
sports events. It is clear, however, that CHO supplementation represents a practical and 550 
effective intervention to constrain the deterioration of CP during endurance exercise. 551 
  552 
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Figure Legends  740 
Figure 1. The group mean power profiles during the 3-min all-out test (3MT) measured with 741 
no prior exercise (C-3MT), and when preceded by 40 min (40-3MT), 80 min (80-3MT) and 2 742 
h (120-3MTPLA) of heavy-intensity exercise. Error bars are not shown for clarity. The end test 743 
power was significantly reduced at 2 h compared to control and the work done above the end 744 
test power was significantly reduced at 80 min and at 2 h. See text for further details. 745 
 746 
Figure 2. Group mean end test power (A), work done above end test power (B), peak power 747 
outputs (C) and total work done (D) during the 3-min all-out test (3MT) measured with no 748 
prior exercise (C-3MT), and following 40 min (40-3MT), 80 min (80-3MT) and 2 h (120-749 
3MTPLA) of heavy-intensity exercise. a = different from C-3MT (P<0.05), b = different from 750 
40-3MT (P<0.005), c = different from 80-3MT (P<0.05). 751 
 752 
Figure 3. Group mean relative intensity (%V̇O2peak) (panel A), respiratory exchange ratio 753 
(panel B), carbohydrate oxidation (panel C) and blood [glucose] and [lactate] (panel D) 754 
during 2 h of heavy-intensity cycling while ingesting carbohydrate (white symbols) or 755 
placebo (black symbols). * = different from placebo (P<0.05), a = different from 10-15 min 756 
(P<0.05), b = different from 25-30 min (P<0.05), c = different from 55-60 min (P<0.05), d = 757 
different from 85-90 min (P<0.05), $= different from baseline (P<0.05), £ = different from 20 758 
min (P<0.05). 759 
 760 
Figure 4. The group mean power profiles during the 3-min all-out test (3MT) measured with 761 
no prior exercise (C-3MT) and when preceded by a 2 h-heavy intensity exercise bout with 762 
ingestion of carbohydrate (120-3MTCHO) or placebo (120-3MTPLA). Error bars are not shown 763 
for clarity. The end test power was significantly reduced at 2 h compared to control when 764 
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placebo was ingested but was not different to control when carbohydrate was ingested. The 765 
work done above the end test power was significantly reduced compared to control 766 
irrespective of placebo or carbohydrate ingestion. See text for further details. 767 
 768 
Figure 5. Group mean ± SD end test power (A), work done above end test power (B), peak 769 
power outputs (C), and total work done (D) during the 3-min all-out test measured with no 770 
prior exercise (C-3MT) and after 2 h of exercise while ingesting carbohydrates (120-3MTCHO) 771 
or placebo (120-3MTPLA). * = significant difference (P<0.05). 772 
 773 
Figure 6. Group mean ± SD muscle [glycogen] before and after 2 h of heavy-intensity 774 
exercise while consuming carbohydrate (CHO) or placebo (PLA).  a = different from pre-775 
exercise values (P<0.001), b = different from CHO condition (P<0.05). 776 
 777 
Figure 7. Combined results from present study (black circles) and Clark et al. (13) (white 778 
circles) (n=28). Correlation between muscle [glycogen] at rest and end test power (EP) 779 
without preceding exercise (panel A) and correlation between muscle [glycogen] and EP after 780 
2 h of heavy-intensity exercise (B). Correlations between the percentage change in muscle 781 
[glycogen] and the absolute (panel C) and percentage (panel D) change in EP over 2 h of 782 
heavy-intensity exercise. Correlations between the percentage change in muscle [glycogen] 783 
and the absolute (panel E) and percentage (panel F) change in WEP over 2 h of heavy-784 
intensity exercise. ** = P<0.005; * = P<0.05. 785 
Table 1. Mean ± S.D. body mass, heart rate and RER during heavy-intensity exercise 
performed for various durations of heavy-intensity exercise 
 
 Body mass (kg) Heart Rate (b•min-1) RER 
Pre exercise Post exercise 10 - 15 min Last 5 min   of exercise 10 - 15min 
Last 5 min   
of exercise 
40-3MT 79.2 ± 7.6 78.9 ± 7.6ab 134 ± 16 138 ± 16ab 0.93 ± 0.03 0.92 ± 0.04b 
80-3MT 79.3 ± 7.6 78.7 ± 7.5ab 133 ± 15 141 ± 17ab 0.93 ± 0.04 0.91 ± 0.05ab 
120-3MTPLA 79.2 ± 7.5 78.2 ± 7.3a 134 ± 18 150 ± 16a 0.91 ± 0.04 0.84 ± 0.05a 
120-3MTCHO 79.4 ± 7.6 78.5 ± 7.4a 130 ± 16 149 ± 17a 0.90 ± 0.05 0.87 ± 0.04ab 
 
40-3MT, 40 min of heavy-intensity exercise; 80-3MT, 80 min of heavy-intensity exercise; 120-3MTPLA, 120 min of 
heavy-intensity exercise consuming water; 120-3MTCHO, 120 min of heavy-intensity exercise consuming carbohydrates. a = different from start of exercise measurements, P<0.05; b = different from 120-3MTPLA. , P<0.05. 
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